Meeting Report: The Dallas Consensus Conference on Liver Transplantation for Alcohol Associated Hepatitis

Sumeet K. Asrani, James Trotter, Jack Lake, Aijaz Ahmed, Anthony Bonagura, Andrew Cameron, Andrea DiMartini, Stevan Gonzalez, Gene Im, Paul Martin, Philippe Mathurin, Jessica Mellinger, John P. Rice, Vijay H. Shah, Norah Terrault, Anji Wall, Scott Winder, Goran Klintmalm – 19 November 2019 – Liver transplantation (LT) for alcohol associated hepatitis (AH) remains controversial. We convened a consensus conference to examine various aspects of LT for AH.

Autologous Adipose Tissue–Derived Mesenchymal Stem Cells Introduced by Biliary Stents or Local Immersion in Porcine Bile Duct Anastomoses

Yi Zhang, Ayushman Sharma, Dong Jin Joo, Erek Nelson, Anan AbuRmilah, Bruce P. Amiot, Christen J. Boyer, Jonathan S. Alexander, Nidhi Jalan‐Sakrikar, John Martin, Roger Moreira, Shiraj A. Chowdhury, Michele Smart, Allan B. Dietz, Scott L. Nyberg, Julie K. Heimbach, Robert C. Huebert – 19 November 2019 – Biliary complications (strictures and leaks) represent major limitations in living donor liver transplantation. Mesenchymal stem cells (MSCs) are a promising modality to prevent biliary complications because of immunosuppressive and angiogenic properties.

Attributable Fractions of Nonalcoholic Fatty Liver Disease for Mortality in the United States: Results From the Third National Health and Nutrition Examination Survey With 27 Years of Follow‐up

Subscribe to